The high-risk human papillomavirus (HPV) has been identified as the cause of cervical cancer, the second most common form of cancer in women, and its discoverer, German scientist Harald Trul. Trul. The discoverer, German scientist Harald Trull-Hauser, was awarded the 2008 Nobel Prize in Medicine for this work. High-risk HPV typing tests are gaining more and more attention. The high-risk HPV typing test allows people to know if this high-risk HPV virus is present in the cervix, especially HPV16 and HPV18. If the virus test result is negative, of course, it is best; if the test result is positive, it may not directly suggest cervical cancer, but also needs to be diagnosed by cervical three-stage normalization; if cervical cancer and precancerous lesions are excluded, it proves that at this moment it is only high-risk HPV infection of the cervix. In this case, the accurate interpretation is that the test results suggest low systemic immune function and/or low local immune function of the cervix. The means of response is to strengthen systemic immune function, including a regular life, a balanced diet, a good state of mind and active improvement of immune function in the lower genital tract, treatment of cervicitis and vaginitis, and use of instrumental contraception to intercept various infections in the lower genital tract. With the above comprehensive measures, high-risk HPV can be kept away from women early, so that precancerous lesions will not develop and cervical cancer will not occur. For those who have been diagnosed with precancerous cervical lesions, in addition to standardized treatment, in order to prevent recurrence, high-risk HPV typing test can also be used to do a good job of tracking and follow-up, which is usually recommended to be followed up for 20 years after cervical lesion treatment.